JOAPR_image

About the Journal

Journal of Applied Pharmaceutical Research (JOAPR), ISSN No. 2348-0335 is an official publication of Creative Pharma Assent (CPA). It is an open access, peer reviewed online Journal. JOAPR primarily focuses on publication of manuscript related to multiple disciplines of pharmaceutical sciences (Pharmaceutics, Pharmaceutical Technology, Biopharmaceutics, Cosmetic Technology, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Herbal drugs/ formulations, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy). JOAPR is published quarterly. JOAPR also includes evaluation of pharmaceutical excipients & their practical application to research & industry based efforts. The aim of the scientific journal, JOAPR is to present a wide area for the current researchers to share their noble works and ideas in terms of the research papers, review articles and short communications. JOAPR only publishes original research works with a definite innovation and novelty after thorough plagiarism checking and peer reviewing. The paper must have a suitable and proper scientific background.

Brief Information about JOAPR

  • Journal Title: Journal of Applied Pharmaceutical Research
  • Journal Abbreviation: J. Appl. Pharm. Res.
  • Publisher: Creative Pharma Assent
  • Country: India
  • Language: English
  • Publishing Frequency: Quarterly
  • Editor In Chief: Prof. Amit Roy
  • Editorial Office: Plot No. 105/42, Opposite electricity sub station, Changorabhata, Raipur (CG) 492001, India
  • Regional Office: Bishnupath, Rukminigoan, Dispur, Guwahati, Assam, PIN-781022
  • Phone: +91-8349444385 ; +91-9770019143
  • E-mail: editor@japtronline.com ; japr.editor@gmail.com
  • Website: https://www.japtronline.com
  • Publication: Online only
  • e-ISSN: 2348-0335
  • CODEN: JAPRIV
  • Year of Start: 2013
  • Review Process: Double-blind peer review

Current Issue

Vol. 8 No. 3 (2020)
View All Issues